Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Aztreonam: monocenter microbiological study with prevention experience in surgery].

A Malcangi1, S Pesce, M Vitale

  • 1Istituto di Microbiologia e I Clinica Chirurgica Generale e Terapia Chirurgica, Università di Torino.

Giornale Di Batteriologia, Virologia Ed Immunologia
|January 1, 1987
PubMed
Summary

Aztreonam, a monobactam antibiotic, demonstrates potent activity against aerobic gram-negative bacteria, including Pseudomonas species, with high susceptibility in urinary tract isolates. This study supports its use for treating urinary tract infections and for surgical prophylaxis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative species distribution model framework for marine conservation and its application to loggerhead turtles in the Mediterranean.

Conservation biology : the journal of the Society for Conservation Biology·2026
Same author

From juveniles to adults: Ontogenetic and seasonal patterns of loggerhead turtles in oceanic Mediterranean habitats.

Marine environmental research·2026
Same author

Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes.

Diabetes research and clinical practice·2024
Same author

Independent association of estimated pulse-wave velocity with all-cause mortality in individuals with type 2 diabetes.

QJM : monthly journal of the Association of Physicians·2024
Same author

A compact-rigid multi-analyser for energy and angle filtering of high-resolution X-ray experiments. Part 2. Efficiency of a single-crystal-comb.

Journal of synchrotron radiation·2023
Same author

Paediatric Orthodontics. Part 4: SEC III protocol in Class III malocclusion.

European journal of paediatric dentistry·2019

Area of Science:

  • Microbiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Aerobic gram-negative bacteria are common causes of urinary tract infections (UTIs).
  • Aztreonam is a synthetic monobactam antibiotic with a specific spectrum of activity.
  • Evaluating new antibiotics for UTIs and surgical prophylaxis is crucial.

Purpose of the Study:

  • To determine the in vitro susceptibility of urinary tract isolates to aztreonam and other beta-lactam antibiotics.
  • To assess the clinical efficacy, pharmacokinetics, and safety of aztreonam in patients with UTIs.
  • To evaluate aztreonam's safety for perioperative prophylaxis.

Main Methods:

  • Antimicrobial susceptibility testing of 127 urinary tract isolates against aztreonam, cefotaxime, cefonicid, and ceftazidime.

Related Experiment Videos

  • Clinical case studies of two patients treated for UTIs, monitoring serum and urine aztreonam concentrations.
  • Safety evaluation in 20 patients receiving aztreonam for surgical prophylaxis.

    • Main Results:

    • Aztreonam exhibited significant antibacterial activity against aerobic gram-negative bacteria, including Pseudomonas spp.
    • Only 7 out of 127 isolates showed resistance to aztreonam.
    • Clinical data indicated aztreonam's efficacy and favorable pharmacokinetic profile in UTIs, with good safety in surgical prophylaxis.

    Conclusions:

    • Aztreonam is a highly effective antibiotic against common gram-negative urinary pathogens.
    • Its pharmacokinetic properties and safety profile support its use in treating UTIs.
    • Aztreonam shows promise as a prophylactic agent for surgical procedures.